Vendor, Portland, OR
Klarquist Sparkman, LLP
UEI C75KZNSK3CL4, CAGE 3WKA9
9 awards and -$630,019 obligated between July 31, 2026 and September 8, 2026, 100% under full and open competition, against 3.7 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Food and Drug Administration | $47,587 |
| National Institutes of Health | -$677,606 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 9 |
| Delivery Order | 9 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93025F00238Delivery Order, September 8, 2026, Full and Open Competition, 5 offers | National Institutes of Health NiaidNational Institutes of Health | Contract# 75N98020D00049; Klarquist; Niaid Bio; Pop 09/09/2026 - 09/08/2027; Can/Project 8072249/162948; Total Amount $857,634.00NAICS 541110, PSC R418 | $857,634 |
| 75F40124F19002Delivery Order, August 10, 2026, Full and Open Competition | FDA Office of Acq Grant SVCSFood and Drug Administration | Time and Materials Award Office of the Commissioner (Oc) - Patent Legal Services Cor: Octavis Lampkin Octavis.Lampkin@fda.Hhs.Gov Technical NAICS 541110, PSC R418 | $650,000 |
| 75N93021F00163Delivery Order, August 10, 2026, Full and Open Competition, 1 offers | National Institutes of Health NiaidNational Institutes of Health | To Administrate De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation fNAICS 541110, PSC R418 | -$2,442 |
| 75N93020F00045Delivery Order, August 6, 2026, Full and Open Competition, 1 offers | National Institutes of Health NiaidNational Institutes of Health | To Administrate De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation fNAICS 541110, PSC R418 | -$2,627 |
| 75N93020F00084Delivery Order, August 7, 2026, Full and Open Competition, 9 offers | National Institutes of Health NiaidNational Institutes of Health | To Administrate De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation fNAICS 541110, PSC R418 | -$4,368 |
| 75N93021F00215Delivery Order, August 10, 2026, Full and Open Competition, 1 offers | National Institutes of Health NiaidNational Institutes of Health | Purpose: to Administratively De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in NAICS 541110, PSC R418 | -$5,800 |
| 75N93021F00334Delivery Order, August 11, 2026, Full and Open Competition, 1 offers | National Institutes of Health NiaidNational Institutes of Health | To Administrate De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation fNAICS 541110, PSC R418 | -$12,206 |
| 75F40122F19001Delivery Order, July 31, 2026, Full and Open Competition | FDA Office of Acq Grant SVCSFood and Drug Administration | Deobligation/CloseoutNAICS 541110, PSC R418 | -$602,413 |
| 75N91021F00156Delivery Order, August 13, 2026, Full and Open Competition, 8 offers | NIH NCINational Institutes of Health | 2026 Udo Closeout Initiative - the Purpose of This Modification Is to Deobligate Unused Funds on This Expired Time and Materials Contract inNAICS 541110, PSC R418 | -$1,507,796 |
- Product and service codes
- R418 Legal Services
- Transactions
- 9 across 9 awards